TY - JOUR
T1 - Isocoumarins as estrogen receptor beta selective ligands
T2 - Isomers of isoflavone phytoestrogens and their metabolites
AU - De Angelis, Meri
AU - Stossi, Fabio
AU - Waibel, Michael
AU - Katzenellenbogen, Benita S.
AU - Katzenellenbogen, John A.
N1 - Funding Information:
This work was supported through grants from the National Institutes of Health (PHS 5R37 CA25836 and P01 AG024387A 4 to J.A.K., and PHS 5R01 CA19118 to B.S.K.). We are grateful to Kathryn Carlson for binding assays and for comments on the manuscript. NMR spectra were obtained in the Varian Oxford Instrument Center for Excellence in NMR Laboratory. Funding for the instrumentation was provided in part by the W.M. Keck Foundation, the National Institutes of Health (PHS 1 S10 RR104444-01) and the National Science Foundation (NSF CHE 96-10502). Mass spectra were obtained on instruments supported by grants from the National Institute of General Medical Sciences (GM 27029), the National Institutes of Health (RR 01575), and the National Science Foundation (PCM 8121494).
PY - 2005/12/1
Y1 - 2005/12/1
N2 - In a search for new ligands selective for the estrogen receptor beta (ERβ), we prepared a series of non-steroidal compounds having an isocoumarin core structure. An interesting feature of these derivatives is that they bear the same functionalities as the well-known ERβ -selective, isoflavone phytoestrogens daidzein and genistein, but in an isomeric arrangement. These compounds could be prepared efficiently by electrophilic cyclization of acetylenic ester precursors, followed by simple manipulations to introduce additional substituents. Through a reduction of some of the isocoumarins, we also obtained isomeric analogs of the isoflavone metabolites equol and dehydroequol. The compounds we prepared were evaluated in ER binding assays, and selected compounds were studied further in cell-based gene transcription assays. Several of the isocoumarins and their analogs are high-affinity ligands that show considerable selectivity for ERβ in terms of binding affinity, and strikingly high ERβ selectivity in terms of potency in gene transcription assays. Two of the best compounds, which combine high transcriptional potency with an ERβ selectivity greater than 1000, should prove to be excellent probes of ERβ function in vivo.
AB - In a search for new ligands selective for the estrogen receptor beta (ERβ), we prepared a series of non-steroidal compounds having an isocoumarin core structure. An interesting feature of these derivatives is that they bear the same functionalities as the well-known ERβ -selective, isoflavone phytoestrogens daidzein and genistein, but in an isomeric arrangement. These compounds could be prepared efficiently by electrophilic cyclization of acetylenic ester precursors, followed by simple manipulations to introduce additional substituents. Through a reduction of some of the isocoumarins, we also obtained isomeric analogs of the isoflavone metabolites equol and dehydroequol. The compounds we prepared were evaluated in ER binding assays, and selected compounds were studied further in cell-based gene transcription assays. Several of the isocoumarins and their analogs are high-affinity ligands that show considerable selectivity for ERβ in terms of binding affinity, and strikingly high ERβ selectivity in terms of potency in gene transcription assays. Two of the best compounds, which combine high transcriptional potency with an ERβ selectivity greater than 1000, should prove to be excellent probes of ERβ function in vivo.
KW - Equol
KW - Estrogen receptor alpha
KW - Estrogen receptor beta
KW - Genistein
KW - Isocoumarin
UR - http://www.scopus.com/inward/record.url?scp=27544470970&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=27544470970&partnerID=8YFLogxK
U2 - 10.1016/j.bmc.2005.07.014
DO - 10.1016/j.bmc.2005.07.014
M3 - Article
C2 - 16099659
AN - SCOPUS:27544470970
SN - 0968-0896
VL - 13
SP - 6529
EP - 6542
JO - Bioorganic and Medicinal Chemistry
JF - Bioorganic and Medicinal Chemistry
IS - 23
ER -